Analysts expect Express Scripts to report meaningful growth for both revenue and earnings for its second quarter. The average analyst estimate is for adjusted EPS and revenue of $1.40 and $26.15 ...

Express Scripts Holding Company (Nasdaq: ESRX) is a Nasdaq-100 company that believes "diversity and inclusion are the foundation on which success and growth are built." This company walks the talk, ...

ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced it has earned URAC accreditation for Workers' Compensation Pharmacy Benefit ...

Express Scripts Holding Company (NASDAQ:ESRX) — the largest pharmacy benefit manager, or PBM, in America — is also one of the most important companies in the health care industry. PBMs fill ...

Express Scripts Holding Company (NASDAQ:ESRX) is the obvious Babe Ruth of the pharmacy benefit management space, and a steady year-to-date return of nearly 20% indicates that investors are using it to ...

The recent offer from Cigna provides an excellent opportunity to buy Express Scripts with limited downside. Express Script's CEO is very long Express while Cigna's CEO is short Cigna. Express is ...

The $3.6 billion purchase of private equity-backed eviCore Healthcare marks Express Scripts’ largest deal since its acquisition of Medco Health Solutions in 2012 for more than $29 billion. Pharmacy ...

Healthcare management and administration service company Express Scripts is scheduled to report second-quarter results on Tuesday, July 28 after market close. With shares hitting all-time highs before ...

On Tuesday, October 27, Express Scripts (ESRX) will announce its third-quarter results after the market closes. While shares have pulled back about 7% since it last reported results, the healthcare ...

What investors need to know before Express Scripts reports second-quarter results. Expectations Analysts expect Express Scripts to report meaningful growth for both revenue and earnings for its second ...